Business Segments WuXi AppTec Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 13/09/2024			5-day change	1st Jan Change
39.82 ^CNY	+0.15%		+2.63%	-45.27%

12/09	US Biosecure Act Could Boost South Korean Biotech Companies, Report Says	MT
11/09	WuXi AppTec Plans 1 Billion Yuan Share Buyback in Shanghai	MT

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment

Fiscal Period: December	2019	2020	2021	2022	2023
Life Sciences Tools and Services
Chemical Business	-	-	14.09B	28.85B	29.17B
Gross Profit	-	-	5.57B	11.54B	12.99B
Wuxi Biology	-	-	1.99B	2.48B	2.55B
Gross Profit	-	-	769M	959M	1.03B
Cell and Gene Therapy CTDMO Business	-	-	1.03B	1.31B	1.31B
Gross Profit	-	-	-20.79M	-87.36M	-131M
Wuxi DDSU	-	-	1.25B	970M	726M
Gross Profit	-	-	549M	254M	260M
Clinical Research and Other CRO Services	1.06B	1.17B	-	-	-
Gross Profit	258M	171M	-	-	-
US District Laboratory Services	1.56B	1.52B	-	-	-
Gross Profit	475M	329M	-	-	-
Laboratory Services in China	6.47B	8.55B	-	-	-
Gross Profit	2.78B	3.59B	-	-	-
Pharmaceutical Contract Laboratories
Wuxi Testing	-	-	4.53B	5.72B	6.54B
Gross Profit	-	-	1.43B	1.99B	2.45B
Unallocated Other	21.22M	22.1M	27.52M	33.61M	41.05M
Gross Profit	3.05M	11.52M	13.1M	15.71M	20.99M
Pharmaceutical Contract Research Organization
Small molecule new drug research and development platform construction project	3.75B	5.28B	-	-	-
Gross Profit	1.5B	2.18B	-	-	-

Geographical breakdown of sales

Fiscal Period: December	2019	2020	2021	2022	2023
Overseas	9.91B	-	17.1B	31.83B	32.97B
Total Assets	-	3.52B	-	-	-
China	2.97B	4.15B	5.77B	7.49B	7.33B
Total Assets	-	-	-	-	-
Rest of world	-	198M	-	-	-
Total Assets	-	12.69B	-	-	-
U.S.	-	8.86B	-	-	-
Asia	-	680M	-	-	-
Rest of	-	-	-	-	-
Asia (Except China)	-	-	-	-	-
Europe	-	2.65B	-	-	-
United States	-	-	-	-	-